| Authors: |
Jager MJ; Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands. m.j.jager@lumc.nl., Shields CL; Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA., Cebulla CM; Havener Eye Institute, Department of Ophthalmology and Visual Science, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Abdel-Rahman MH; Havener Eye Institute, Department of Ophthalmology and Visual Science, The Ohio State University Wexner Medical Center, Columbus, OH, USA.; Division of Human Genetics, Department of Internal Medicine, The Ohio State University Columbus, Columbus, OH, USA., Grossniklaus HE; Department of Ophthalmology, Emory University, Atlanta, GA, USA.; Department of Pathology and Laboratory Medicine, Emory University Atlanta, GA, USA., Stern MH; Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.), Equipe labellisée par la Ligue Nationale Contre le Cancer, Institut Curie, PSL Research University, Paris, France., Carvajal RD; Department of Medicine, Columbia University Medical Center, New York, NY, USA., Belfort RN; Department of Ophthalmology and Visual Sciences, Federal University of São Paulo, São Paulo, Brazil., Jia R; Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Shields JA; Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA., Damato BE; Nuffield Department of Clinical Neurosciences, University of Oxford, West Wing, John Radcliffe Hospital, Oxford, UK. |
